Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

References

• Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P. (2002). Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res, 952: 128–134.
   PubMed Web of Science ®Google Scholar
• Anderson KD, Panayotatos N, Corcoran TL, Lindsay RM, Wiegand SJ. (1996). Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci USA, 93: 7346–7351.
   PubMed Web of Science ®Google Scholar
• Arancibia S, Silhol M, Mouliere F, Meffre J, Hollinger I, Maurice T, Tapia-Arancibia L. (2008). Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis, 31:316–326.
   PubMed Web of Science ®Google Scholar
• Azadi S, Johnson LE, Paquet-Durand F, Perez MTR, Zhang Y, Ekstrom PAR, van Veen T. (2007). CNTF + BDNF treatment and neuroprotective pathways in the rd1 mouse retina. Brain Res, 1129: 116–129.
   PubMed Web of Science ®Google Scholar
• Azoulay D, Urshansky N, Karni A. (2008). Low and dysregulated BDNF-secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol, 195: 186–193.
   PubMed Web of Science ®Google Scholar
• Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W. 2004. Intranasal insulin improves memory in humans. Psychoneuroendocrinology, 29: 1326–1334.
   PubMed Web of Science ®Google Scholar
• Benedict C, Hallschmid M, Schultes B, Born J, Kern W. (2007). Intranasal insulin to improve memory function in humans. Neuroendocrinology, 86: 136–142.
   PubMed Web of Science ®Google Scholar
• Benedict C, Kern W, Schultes B, Born J, Hallschmid M. (2008). Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab, 93: 1339–1344.
   PubMed Web of Science ®Google Scholar
• Blits B, Oudega M, Boer GJ, Barlett Bunge M, Verhaagen J. (2003). Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience, 118: 271–281.
   PubMed Web of Science ®Google Scholar
• Born J, Lange T, kern W, McGregor GP, Bickel U, Fehm HL. (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci, 5: 514–516.
   PubMed Web of Science ®Google Scholar
• Brines ML, Ghezzi P, Keenan SS, Angello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA, 97: 10526–10531.
   PubMed Web of Science ®Google Scholar
• Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J. (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington’s disease. J Neurosci, 24: 7727–7739.
   PubMed Web of Science ®Google Scholar
• Capsoni S, Giannotta S, Cattaneo A. (2002). Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci USA, 99: 12432–12437.
   PubMed Web of Science ®Google Scholar
• Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey WH II. (1998). Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis, 1: 35–44.
   PubMedGoogle Scholar
• Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK, Lim JS, Park HK, Kim M, Lee SK, Roh JK. (2008). Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia, 49: 1723–1732.
   PubMed Web of Science ®Google Scholar
• Clatterbuck RE, Price DL, Koliatsos VE. (1993). Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc Natl Acad Sci USA, 90: 2222–2226.
   PubMed Web of Science ®Google Scholar
• Danielyan L, Mueller L, Proksch B, Kabisch D, Weller M, Wiesinger H, Buniatian GH, Gleiter CH. (2005). Similar protective effects of BX-123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injury. Eur J Cell Biol, 84: 907–913.
   PubMed Web of Science ®Google Scholar
• Deckner ML, Frisen J, Verge VM, Hokfelt T, Risling M. (1993). Localization of neurotrophin receptors in olfactory epithelium and bulb. Neuroreport, 13: 301–304.
   Google Scholar
• De Rosa R, Garcia A, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A. (2005). Intranasal administration of NGF rescues recognition memory deficits in anti-NGF transgenic mice. Proc Natl Acad Sci USA, 102: 3811–3816. Dhanda DS, Frey II WH, Leopold D, Kompella UB. (2005). Nose-to-brain delivery: Approaches for drug deposition in the human olfactory epithelium. Drug Delivery Technol, 5: 64–72.
   Google Scholar
• Diem R, Sattler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bahr M. (2005). Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain, 128: 375–385.
   PubMed Web of Science ®Google Scholar
• Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA. (2004). Acute neuroprotective synergy of erythropoietin and insulin-like growth factor 1. Proc Natl Acad Sci USA, 101: 9855–9860.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Cain CK, Greco C, Saydoff JA, Hu ZY, Liu H, Lindner MD. (1997). Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington’s disease. Cell Transplant, 6: 249–266.
   PubMed Web of Science ®Google Scholar
• Endres M, Fan G, Hirt L, Jaenisch R. (2003). Stroke damage in mice after knocking the neurotrophin-4 gene into the brain-derived neurotrophic factor locus. J Cereb Blood Flow Metab, 23: 150–153.
   PubMed Web of Science ®Google Scholar
• Ferrer I, Planas AM. (2003). Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol, 62: 329–339.
   PubMed Web of Science ®Google Scholar
• Fischer AJ, Schmidt M, Omar G, Reh TA. (2004). BMP4 and CNTF are neuroprotective and suppress damage-induced proliferation of Muller glia in the retina. Mol Cell Neurosci, 27: 531–542.
   PubMed Web of Science ®Google Scholar
• Francis GJ, Martinez JA, Liu WQ, Xu K, Ayer A, Fine J, Tuor UI, Glazner G, Hanson LR, Frey II WH, Toth C. (2008). Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain, 131: 3311–3334.
   PubMed Web of Science ®Google Scholar
• Francis G, Martinez J, Liu W, Nguyen T, Ayer A, Fine J, Zochodne D, Hanson LR, Frey II WH, Toth C. (2009). Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes, 58: 934–945.
   PubMed Web of Science ®Google Scholar
• Frey WH, Liu J, Chen X, Thorne RG, Fawcett JR, Ala TA, Rahman YE. (1997). Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv, 4: 87–92.
   Web of Science ®Google Scholar
• Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, Iacopino DG. (2007). Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res, 182: 99–105.
   Google Scholar
• Hallschmid M, Benedict C, Born J, Fehm HL, Kern W. (2004). Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol Behav, 30: 55–64.
   Google Scholar
• Hallschmid M, Benedict C, Schultes B, Born J, Kern W. (2008). Obese men respond to cognitive but not to catabolis brain insulin signaling. Int J Obes (Lond), 32: 275–282.
   PubMed Web of Science ®Google Scholar
• Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 350: 230–232.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Tatsuno T, Noguchi H, Nakayama C. (2004). Ciliary neurotrophic factor protects rat retina cells in vitro and in vivo via PI3 kinase. Curr Eye Res, 29: 349–355.
   PubMed Web of Science ®Google Scholar
• Illum L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol, 56: 3–17.
   PubMed Web of Science ®Google Scholar
• Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O. (1993). Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA, 90: 6711–6715.
   PubMed Web of Science ®Google Scholar
• Lee MY, Hofmann HD, Kirsch M. (1997). Expression of ciliary neurotrophic factor receptor-alpha messenger RNA in neonatal and adult rat brain: an in situ hybridization study. Neuroscience, 68: 979–990.
   Google Scholar
• Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G. (1994). Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. NeuroReport, 5: 865–868.
   PubMed Web of Science ®Google Scholar
• Lindholm D, Dechant G, Heisenberg CP, Thoenen H. (1993). Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci, 5: 1455–1464.
   PubMed Web of Science ®Google Scholar
• Liu XF, Fawcett JR, Hanson LR, Frey WH II. (2004). The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J Stroke Cerebrovasc Dis, 13: 16–23.
   PubMedGoogle Scholar
• Liu XF, Fawcett JR, Thorne RG, DeFor T, Frey II WH. (2001). Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett, 308: 91–94.
   PubMed Web of Science ®Google Scholar
• Magal E, Louis JC, Oudega M, Varon S. (1993). CNTF promotes the survival of neonatal rat corticospinal neurons in vitro. NeuroReport, 4: 779–782.
   PubMed Web of Science ®Google Scholar
• Mandel RJ, Gage FH, Clevenger DG, Spratt SK, Snyder RO, Leff SE. (1999). Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Exp Neurol, 155: 59–64.
   PubMed Web of Science ®Google Scholar
• Merkus P, Guchelaar HJ, Bosch A, Merkus FWHM. (2003). Direct access of drugs to the human brain after intranasal drug administration? Neurology, 60: 1669–1671.
   PubMed Web of Science ®Google Scholar
• Merkus, FWHM, van den Berg MP. (2007). Can nasal drug delivery by-pass the blood-brain barrier? Drugs RD, 8: 133–144.
   PubMedGoogle Scholar
• Misra A, Ganesh S, Shahiwala A, Shah SP. (2003). Drug delivery to the central nervous system: a review. J Pharm Pharmaceut Sci, 6: 252–273.
   PubMed Web of Science ®Google Scholar
• Nowis D, Legat M, Bil J, Kurzaj Z, Issat T, Stoklosa T, Mioduszewska B, Kaczmarek L, Jakobisiak M, Golab J. (2007). Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. Int J Oncol, 31: 1547–1552.
   PubMed Web of Science ®Google Scholar
• Park K, Luo JM, Hisheh S, Harvey AR, Cui Q. (2004). Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J Neurosci, 24: 10806–10815.
   PubMed Web of Science ®Google Scholar
• Pietrowsky R, Struben C, Molle M, Fehm HL, Born J. (1996). Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-to-brain pathway for peptide effects in human. Biol Psychiat, 39: 332–340.
   PubMed Web of Science ®Google Scholar
• Poduslo JF, Curran GL. (1996). Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol Brain Res, 36: 280–286.
   PubMedGoogle Scholar
• Qu HY, Zhang T, Li XL, Zhou JP, Zhao BQ, Li Q, Sun MJ. (2008). Transducible P11-CNTF rescues the learning and memory impairments induced by amyloid-beta peptide in mice. Eur J Pharmacol, 594: 93–100.
   PubMed Web of Science ®Google Scholar
• Rabbacchi SA, Kruk B, Hamilton J, Carney C, Hoffman JR, Meyer SL, Springer JE, Baird DH. (1999). BDNF and NT4/5 promote survival and neurite outgrowth of pontocerebellar mossy fiber neurons. J Neurobiol, 40: 254–269.
   PubMedGoogle Scholar
• Rami A, Bechmann I, Stehle JH. (2008). Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia. Prog Neurobiol, 85: 273–296.
   PubMed Web of Science ®Google Scholar
• Reger MA, Watson GS, Frey WH II, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S. (2006). Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype. Neurobiol Aging, 27: 451–458.
   PubMed Web of Science ®Google Scholar
• Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S. (2008). Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology, 70: 440–448.
   PubMed Web of Science ®Google Scholar
• Royo NC, Conte V, Saatman KE, Shimizu S, Belfield CM, Soltesz KM, Davis JE, Fujimoto ST, McIntosh TK. (2006). Hippocampal vulnerability following traumatic brain injury: a potential role for neurotrophin-4/5 in pyramidal cell neuroprotection. Eur J Neurosci, 23: 1089–1102.
   PubMed Web of Science ®Google Scholar
• Sadick MD, Galloway A, Shelton D, Hale V, Weck S, Anicetti V, Wong WL. (1997). Analysis of neurotrophin/receptor interactions with a gD-flat-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay. Exp Cell Res, 234: 354–361.
   PubMed Web of Science ®Google Scholar
• Sakanaka M, Wen TC, Matsuda S, Morishita E, Nagao M, Sasaki R. 1998. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA, 95: 4635–4640.
   PubMed Web of Science ®Google Scholar
• Samelson LE. (2001). Iodination of soluble and membrane-bound proteins. Curr Protoc Immunol Chapter 8: Unit 8.11.
   Google Scholar
• Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H. (2001). Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol, 101: 271–276.
   PubMed Web of Science ®Google Scholar
• Skaper SD, Negro A, Dal Toso R, Facci L. (1992). Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: synergistic effects of monosialogangliosides. J Neurosci Res, 33: 330–337.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhou H, Luo X, Li S, Yu D, Hua J, Mu D, Mao M. (2008). Neuroprotection of brain-derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Int J Dev Neurosci, 26: 363–370.
   PubMed Web of Science ®Google Scholar
• Tapia-Arancibia L, Aliaqa E, Silhol M, Arancibia S. (2008). New insights into brain BDNF function in normal aging and Alzheimer’s disease. Brain Res Rev, 59: 201–220.
   PubMed Web of Science ®Google Scholar
• Thoenen H, Sendtner M. (2002). Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nature Neurosci, 5: 1046–1050.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Emory CR, Ala TA, Frey WH. 1995. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res, 692: 278–282.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Frey WH. (2001). Delivery of neurotrophic factors to the brain. Clin Pharmacokinet, 40: 907–946.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH. (2008). Delivery of interferon-b to the monkey nervous system following intranasal administration. Neuroscience, 162: 785–797.
   Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. (2004). Delivery of IGF-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience, 127: 481–496.
   PubMed Web of Science ®Google Scholar
• Tsukahara T, Yonekawa Y, Tanaka K, Ohara O, Watanabe S, Kimura T, Nishijima T, Taniguchi T. (1994). The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery, 34: 323–331.
   PubMed Web of Science ®Google Scholar
• Van Wijngaarden P, Brereton H, Coster DJ, Williams KA. (2007). Stability of housekeeping gene expression in the rat retina during exposure to cyclic hyperoxia. Mol Vis, 13: 1508–1515.
   PubMed Web of Science ®Google Scholar
• Wajchenberg B, Pinto H, Torres de Toledo e Souza I, Lerario AC, Pieroni RR. (1978). Preparation of iodine-125-labeled insulin for radioimmunoassay: Comparison of lactoperoxidase and chloramine-T iodination. J Nucl Med, 19: 900–905.
   PubMed Web of Science ®Google Scholar
• Weise J, Isenmann S, Klocker N, Kugler S, Hirsch S, Gravel C, Bahr M. (2000). Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo. Neurobiol Dis, 7: 212–223.
   PubMed Web of Science ®Google Scholar
• Widmer HR, Knusel B, Hefti F. (1993). BDNF protection of basal forebrain cholinergic neurons after axotomy: complete protection of p75NGFR-positive cells. NeuroReport, 4: 363–366.
   PubMed Web of Science ®Google Scholar
• Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH. (1986). Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA, 83: 9231–9235.
   PubMed Web of Science ®Google Scholar
• Yamada K, Hasegawa M, Kametani S, Ito S. (2007). Nose-to-brain delivery of TS-002, prostaglandin D2 analogue. J Drug Target, 15: 59–66.
   PubMed Web of Science ®Google Scholar
• Yan Q, Elliott J, Snider WD. (1992). Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature, 360: 753–755.
   PubMed Web of Science ®Google Scholar
• Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ. (2005). Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci Lett, 387: 5–10.
   PubMed Web of Science ®Google Scholar
• Zhang QZ, Zha LS, Zhang Y, Jiang WM, Lu W, Shi ZQ, Jiang XG, Fu SK. (2006). The brain targeting efficiency following nasally applied MPED-PLA nanoparticles in rats. J Drug Target, 14: 281–290.
   PubMed Web of Science ®Google Scholar
• Zuccato C, Cattaneo E. (2007). Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol, 81: 294–330.
   PubMed Web of Science ®Google Scholar